Heath Fletcher

Kayla Ellsworth explores why nearly 90% of drug candidates fail and how New Approach Methodologies (NAMs) are transforming drug development. She explains how technologies like AI, omics, advanced in vitro models, and microphysiological systems better replicate human biology, improving research while reducing reliance on animal testing. The conversation also highlights the importance of innovation, women in leadership, and emerging technologies such as brain-on-a-chip that are shaping the future of healthcare. Chapters: 00:00 The Drug Development Crisis 09:08 Introducing New Approach Methodologies (NAMS) 17:53 Exploring NAMS: In Silico to Microphysiological Systems 25:19 Dynamic Microphysiological Systems 26:39 Evidence of Effectiveness in Drug Development 28:48 Speeding Up Drug Development Processes 30:42 Integrating New Approaches in Drug Development 32:17 The Future of Animal Testing 34:21 Women in Leadership and Industry 39:43 Role of Speccro in Drug Development 42:35 Innovations on the Horizon Guest Information:Guest's Name: Kayla Ellsworth Guest's Title/Position: Scientific Operations Coordinator LinkedIn: https://www.linkedin.com/in/kayla-ellsworth-18a2841a0/ Company / Affiliation: SPECCRO https://speccro.com/ Guest's Bio: Kayla Ellsworth is the Scientific Operations Coordinator  at SPECCRO, where she helps connect biotechnology and pharmaceutical companies with innovative preclinical research solutions. Passionate about advancing human-relevant drug development, she works with industry leaders to promote emerging technologies such as organ-on-chip models, iPSCs, and New Approach Methodologies (NAMs). Through her work, Kayla helps foster collaborations that are shaping the future of safer, more predictive drug discovery. Takeaways:The drug development process is failing with a 90% failure rate.NAMS offer innovative solutions to improve drug development.Animal testing is outdated and needs to be replaced.In silico methods use computational modeling for predictions.Omics provides a system-wide insight into biological responses.Spheroids and organoids are advanced models for research.Microphysiological systems are engineered for precise interactions.Networking and taking risks can lead to career opportunities.Effective communication is key in scientific discussions.The future of drug development lies in innovative methodologies. Microphysiological systems mimic blood flow and bodily fluids.These systems are widely used in early drug development.They can save time and money in drug development processes.Not all questions require a microphysiological system.Speccro helps companies incorporate NAMS into their drug development.The goal is to reduce animal studies in drug development.Women supporting women in the industry is crucial for the future.The role at Speccro is dynamic and evolving.Brain on chip devices have immense potential for research.The opportunities for NAMS are truly endless. The Healthy Enterprise Podcast is produced by Bullzeye Global Growth Partners  https://bullzeyeglobal.com/

In this episode, Shashi Ramaiah discusses how outdated drug development practices and regulatory complexity can slow innovation and delay patient access to new therapies. He explains how SPECCRO combines traditional drug development expertise with emerging technologies such as AI, machine learning, organoids, and advanced in vitro models to improve decision-making, reduce risk, and accelerate development timelines. The conversation explores the challenges facing biotech startups, the importance of practical problem-solving, and how collaboration and new technologies are helping shape the future of medicine. Chapters: 00:00 The Challenge of Drug Development 04:00 Bridging Innovation and Regulation 08:43 Integrating New Approaches in Drug Development 12:28 The Role of Speccro in Drug Development 18:40 Building a Team and Client Relationships 23:23 Leveraging Technology and Data 28:18 Onboarding Clients and Problem Solving 31:28 Future Aspirations and Resilience in Startups Guest Information:Guest's Name: Shashi Ramaiah Guest's Title/Position: Founder & CEO LinkedIn: https://www.linkedin.com/in/shashi-ramaiah/ Company / Affiliation: SPECCRO https://speccro.com/ Guest's Bio: Shashi Ramaiah is a drug development executive, scientist, and entrepreneur with deep expertise in preclinical safety, translational pharmacology, toxicology, and regulatory science. He has authored more than 75 peer-reviewed publications and has led drug development programs across academia, biotech, and the pharmaceutical industry. As Founder and CEO of SPECCRO, Shashi is advancing a modern approach to drug development by combining scientific expertise with innovative tools such as New Approach Methodologies (NAMs), advanced in vitro systems, and AI-driven technologies. Through SPECCRO, he helps organizations accelerate development, improve clinical translation, and bring safer therapies to patients more efficiently. Takeaways:Traditional animal models often fail to reflect human biology.There is a need for clear regulatory pathways for new methodologies.Drug development is at a breaking point, requiring innovative solutions.Speccro aims to bridge the gap between innovation and regulation.Startups must unlearn decades of industry thinking to adapt.Practical implementation of new technologies is crucial.Building a strong team is essential for startup success.Leveraging technology and data can enhance drug development processes.Client onboarding should focus on problem-solving and milestone achievements.Resilience and adaptability are key for startups in challenging economic times. The Healthy Enterprise Podcast is produced by Bullzeye Global Growth Partners  https://bullzeyeglobal.com/

In this conversation, Carlos Castan, a fractional CIO, discusses the critical cybersecurity challenges facing healthcare organizations. He emphasizes the importance of compliance with HIPAA regulations, the need for proactive cybersecurity measures, and the role of education in preventing breaches. Carlos also highlights the evolution of his company, DataWorks LLC, and the significance of combining AI with human intelligence to enhance cybersecurity. He shares insights on the future of healthcare IT services and the necessity for organizations to adopt a proactive approach to IT management. Chapters: 00:00 The Cybersecurity Crisis in Healthcare 02:58 Understanding the Role of a Fractional CIO 05:53 The Importance of Compliance and Cybersecurity 08:48 Proactive Measures Against Cyber Threats 11:55 The Human Element in Cybersecurity 14:58 The Evolution of DataWorks 18:04 AI vs. Real Intelligence in Cybersecurity 20:50 Navigating Compliance and Certification 23:52 The Future of Healthcare IT Services 27:07 The Need for Proactive IT Management 30:00 Scaling Healthcare IT Solutions 33:01 The Vision for the Future of Healthcare IT Guest Information:Guest's Name:  Carlos CastanGuest's Title/Position: Co-Founder & Managing PartnerGuest's Linkedin: https://www.linkedin.com/in/carlos-castan/Company / Affiliation: DataWorks LLC https://dataworksllc.com/Guest's Bio: Carlos Castan is the Co-Founder and Managing Partner of DataWorks LLC, a technology consulting and managed services firm that helps organizations align technology investments with business goals. With decades of experience in IT strategy, infrastructure, cybersecurity, and business consulting, Carlos specializes in helping organizations modernize operations, strengthen security, and leverage technology as a driver of growth and organizational impact. Through DataWorks' unique Technology–Impact–Goals (TIG) framework, he works closely with healthcare organizations, professional services firms, and growing businesses to develop practical technology strategies that support long-term success  Takeaways:Healthcare is a prime target for cyberattacks.Many healthcare organizations lack the necessary technology expertise.Compliance with HIPAA is crucial to avoid hefty fines.Cybersecurity breaches can severely damage an organization's reputation.Employee training is essential to prevent cyber threats.AI can enhance cybersecurity but should not replace human intelligence.Proactive IT management can prevent costly breaches.Healthcare organizations need to allocate funds effectively for IT.The demand for healthcare IT services is growing rapidly.Building a network of experts is vital for effective IT management. The Healthy Enterprise Podcast is produced by Bullzeye Global Growth Partners  https://bullzeyeglobal.com/

Katrina Rogers has spent her career helping biotech innovators navigate one of the toughest journeys in business: turning scientific breakthroughs into successful companies. In this episode, she shares why great science alone rarely guarantees success, the hidden challenges that cause promising startups to stall, and the critical role advisors, investors, and strategic networks play in bringing new therapies to market. From fundraising and founder psychology to commercialization and leadership, Katrina offers an inside look at what it really takes to move a biotech company from discovery to exit—and why the biggest obstacles are often the ones founders never see coming. Chapters: 00:00 The Loneliness and Rewards of Founding 01:00 Navigating the Life Sciences Ecosystem 09:57 The Role of Advisors in Drug Development 19:02 Challenges in Fundraising and Pitching 21:20 Building a Convincing Business Case 22:35 Preparing Founders for Success 25:26 The Importance of Education in Entrepreneurship 27:12 Understanding Founder DNA and Team Dynamics 30:16 Trust and Relationships in Investment 31:35 Crafting the Perfect Pitch 35:32 Networking and Community Building 39:08 The Role of Mentorship in Capital Readiness 41:05 Future Endeavors and Learning Opportunities Guest Information:Guest's Name:  Katrina RogersGuest's Linkedin: https://www.linkedin.com/in/katrinarogers/Company / Affiliation: Katrina Rogers Consulting https://krogersconsulting.com/Guest's Bio: Katrina Rogers is the Founder and CEO of Katrina Rogers Consulting, where she advises biotech and life sciences companies on strategy, drug development, commercialization, and organizational growth. With more than 20 years of experience across pharmaceutical research, operations, and business leadership, she helps founders and executives navigate complex challenges, build high-performing organizations, and bring innovative therapies to market. An analytical chemist by training, Katrina is recognized for her ability to bridge science, business strategy, and stakeholder engagement to drive meaningful results.  Takeaways:Being a founder is incredibly lonely but rewarding.Navigating drug development requires expertise in complex biology.Many founders lack the necessary skills for drug development.The contract service industry is crucial for biotech startups.Smaller biotech companies are increasingly driving innovation.Founders often struggle with sales and marketing skills.It's important for founders to recognize when to delegate roles.Advisors can provide critical insights to struggling founders.The fundraising process can be challenging for technical founders.Founders must adapt their vision based on market readiness. Founders need a convincing business case to attract investors.It's crucial to prepare founders for the challenges ahead.Education plays a vital role in guiding entrepreneurs.Understanding founder DNA is key to evaluating teams.Trust is essential in the investment process.Crafting a pitch is about getting to the next meeting.Networking is invaluable for building relationships.Mentorship can significantly enhance capital readiness.Community support is crucial for startup success.Continuous learning is necessary for entrepreneurs. The Healthy Enterprise Podcast is produced by Bullzeye Global Growth Partners  https://bullzeyeglobal.com/

Dr. Kate Stephenson explores the often-overlooked reality of women’s health—particularly vaginal infections that impact millions each year—and why better solutions are long overdue. She introduces CERN’s innovative device, designed to treat these conditions without the side effects of traditional medications, and breaks down the science behind how it works. The conversation also tackles the cultural stigma that keeps these issues in the shadows, the regulatory hurdles of bringing new medical technologies to market, and the importance of building strong networks to advance women’s health innovation. Kate shares her journey as a female engineer and entrepreneur in a male-dominated field, offering insight into resilience, leadership, and the need for more diverse, patient-centered solutions. Chapters: 00:00 The Unspoken Health Crisis for Women 03:00 Innovative Solutions in Women's Health 06:06 Breaking the Silence: Cultural Barriers in Women's Health 08:56 The Science Behind the CERN Device 11:56 Navigating Regulatory Challenges 14:52 The Journey of a Female Engineer in MedTech 17:50 Building a Network for Change 22:47 Navigating Women's Health in Tech 28:53 Overcoming Challenges as a Woman in Engineering 36:40 The Journey of Entrepreneurship and Consulting 41:36 Building Connections in the Bullpen Network 45:58 Future Directions for CERN and Personal Growth Guest Information:Guest's Name:  Dr. Kate StephensonGuest's Title/Position: VP EngineeringGuest's Linkedin: https://www.linkedin.com/in/dyadengineering/Company / Affiliation: CERN Device https://cerndevice.com/Guest's Bio: Dr. Stephenson is a Stanford Engineering PhD with a deep technical consulting background in the design and development of products at life science startups. She has a twenty-year history of strategic early-stage technical projects in a wide range of novel medical products, including medical device, digital health, drug delivery and pharma. A long-term resident of California’s Silicon Valley, her active network spans the life sciences community, including R1 academic centers, major strategics, investors, and startups. Her three key areas of expertise include evaluation of regulated medical products, entrepreneurship education and technical writing. Takeaways:30 million women visit doctors for vaginal infections annually.Vaginal infections are the second leading cause for women in the ER.Current treatments for vaginal infections have not evolved in 40 years.CERN Corporation is developing a device to treat vaginal infections using microbicidal light.Cultural stigma prevents women from discussing their health issues.Women often receive incorrect diagnoses for vaginal infections.The CERN device is designed for home use with no drugs involved.The device uses blue light to target specific pathogens safely.Regulatory challenges exist in bringing innovative women's health devices to market.Networking and education are crucial for advancing women's health initiatives. I am calling the shots and organizing the engineering teams.The end result is helping women get over these health issues.We need to come up not with just one solution, but with a dozen options.The ultimate intent of this product is it's a home use product.The doctors hate it because literally it is the bare bottom value they offer.I joined the boys wrestling team my senior year to support a friend.I realized I had gone through four years of engineering education without a female professor.I want other women engineers to experience being taught by a woman.I'm the kid whose friend got bullied and I took action.I appreciate going to some of these events for networking. The Healthy Enterprise Podcast is produced by Bullzeye Global Growth Partners  https://bullzeyeglobal.com/

In this conversation, Sanjeev Chitre shares his journey as an entrepreneur and the vision behind JuJu Labs, a company rethinking wine through science and technology. He introduces the concept of food-specific wines designed to complement dishes at a molecular level, emphasizing depth through principles like umami and kokumi, and explains how their approach can accelerate the wine aging process from years to just days while preserving complexity and quality. The discussion also explores the challenges facing boutique wineries and how JuJu Labs aims to empower them with tools to create differentiated, experience-driven products, ultimately transforming traditional wine pairing into a more precise and harmonious culinary experience while offering a glimpse into the company’s future and evolving technology. Chapters: 00:00 The Vision of Food-Specific Wines 03:03 Sanjeev's Entrepreneurial Journey 05:57 The Science Behind JuJu Labs 09:09 The Umami Discovery 12:01 Creating Resonance in Wine and Food 15:07 The Challenges of Innovation 17:47 Breaking Down Wine Science 20:59 The Future of Wine and Food Pairing 30:59 Revolutionizing Wine Aging 34:40 The Science Behind JuJu Labs 39:54 Culinary Oenology: A New Experience 44:00 Empowering Boutique Wineries 47:28 The Story Behind JuJu Labs 51:57 Future Innovations and Challenges Guest Information:Guest's Name:  Sanjeev ChitreGuest's Title/Position: Chairman of the Board and CEOGuest's Linkedin: https://www.linkedin.com/in/sanjeev-chitre-a867b74/Company / Affiliation: JuJu Labs Inc.  https://www.jujuwinelab.com/ Guest's Bio: Sanjeev Chitre is the Chairman of the Board and CEO of JuJu Labs Inc., where he is pushing the boundaries of culinary oenology to reimagine traditional wine science. His work integrates the principles of umami and kokumi to create next-generation wine experiences—enhancing depth, savoriness, and a more complete expression of taste. He is also the Managing Partner at The U-Group LLC, where he collaborates with entrepreneurial and corporate leaders to drive shareholder value through operational and financial strategy, strategic partnerships, and capital formation. In addition, he is the author of Father of Nations, a thought-provoking political novel that blends economic theory, global politics, and human storytelling. Takeaways:Sanjeev Chitre aims to create food-specific wines.The wine industry traditionally focuses on pairing, not resonance.Umami is a crucial element missing in grape wines.Sanjeev's entrepreneurial journey began in telecommunications and biomedical instrumentation.The concept of resonance in wine can enhance the dining experience.Innovation in wine faces regulatory challenges from alcohol boards.The science of wine involves understanding dipeptides and tripeptides.Sanjeev's approach combines traditional winemaking with scientific innovation.The JuJu Labs process aims to create a harmonious experience between food and wine.Aging wine is traditionally seen as expensive, but innovation may change that.  Aging wine can be accelerated using scientific methods.JuJu Labs focuses on creating food-specific wines.The company aims to democratize wine for the masses.Culinary oenology is a new field combining food and wine science.Boutique wineries face challenges in marketing and expansion.JuJu Labs partners with existing wineries to enhance their offerings.The essence of JuJu is about transformation in the wine experience.The company is developing commercial-scale equipment for wineries.AI is being integrated to enhance food and wine pairing.JuJu Labs is focused on creating memorable dining experiences.  The Healthy Enterprise Podcast is produced by Bullzeye Global Growth Partners  https://bullzeyeglobal.com/

This episode dives into the high-stakes problem of medication non-adherence and its impact on patient outcomes and healthcare costs. Dr. Anthony Sterns, CEO of iRx Reminder, shares how his team is using cognitive prosthetics and connected devices to improve medication management, patient independence, and mental health monitoring. The conversation also explores the behavioral side of adherence, the realities of scaling healthtech solutions, and practical advice for building in the healthcare space. Chapters: 00:00 The Medication Adherence Crisis 02:48 Introducing iRx Reminder 05:52 Understanding Medication Mismanagement 08:45 Innovative Solutions for Medication Adherence 12:06 Behavioral Insights in Medication Taking 15:08 The Evolution of iRx Reminder 21:53 Engineering Solutions for Health Challenges 25:02 Cognitive Prosthetics and Memory Magic Program 26:26 Medication Adherence and IoT Innovations 28:54 Monitoring Mental Health Through Technology 31:53 The Role of Apps in Patient Engagement 33:03 Navigating the Valley of Death in Healthcare Startups 35:00 Behavioral Health Challenges and Solutions 38:41 Investment Needs and Scaling Challenges 42:10 Advice for Aspiring Entrepreneurs Guest Information:Guest's Name: Dr. Anthony SternsGuest's Title/Position:  Founder and CEOGuest's Linkedin: https://www.linkedin.com/in/anthonysterns/Company / Affiliation:  iRx Reminder https://www.irxreminder.com/Guest's Bio: Anthony Sterns is a CEO, engineer, and organizational psychologist focused on advancing innovation in gerontechnology. He holds a BS in Engineering from University of Michigan and a PhD in Organizational Psychology from University of Akron. A recognized pioneer in technology for aging populations, Anthony holds 12 U.S. patents, has published 33 papers, and delivered over 100 presentations globally. He has led the development of 13 products, bringing six to market. His most widely adopted solution, the Memory Magic Program, is used in more than 2,400 care facilities across seven countries, impacting over 500,000 people living with dementia and their families. Takeaways:700,000 ER visits and 125,000 deaths are avoidable with proper medication adherence.Medication adherence is a major unsolved problem in healthcare.iRx Reminder aims to help patients take medications safely and independently.Many patients struggle with medication management due to cognitive impairments.Situational smart alerting can enhance medication adherence.Patients often forget to refill their prescriptions or feel they no longer need their medications.The average transplant patient takes between 9 to 25 medications.Behavioral psychology plays a crucial role in medication adherence.iRx Reminder's technology focuses on behavioral health diagnoses.The evolution of iRx Reminder reflects a deep understanding of patient needs.  Cognitive prosthetics can significantly aid older adults' socialization.Small process changes can lead to substantial improvements in care.Monitoring mental health through technology is becoming increasingly feasible.Apps can enhance patient engagement and medication adherence.Behavioral health organizations face high disengagement rates.Investment is crucial for scaling healthcare innovations.Building a supportive team is essential for entrepreneurial success.Navigating regulatory challenges is a key hurdle for startups.Understanding patient needs can drive product development.Entrepreneurs must balance personal values with business goals. The Healthy Enterprise Podcast is produced by Bullzeye Global Growth Partners  https://bullzeyeglobal.com/

Women’s leadership, community, and collaboration take center stage in this conversation with Aalyiah Heath and Naomi Cosman, founding members of Club Mamabee. They discuss the power of supportive networks, the challenges women face in securing funding, and how traditionally “nurturing” traits can translate into strong, effective leadership. The conversation also explores the role of storytelling, meaningful connections, and gender diversity in shaping the next generation of female leaders, while highlighting Club Mamabee’s mission to create spaces where women can connect, grow, and support one another. Chapters: 00:00 Empowering Women: Strengths in Leadership 03:12 Building the Hive: Community and Collaboration 05:58 The Importance of Connection: Overcoming Loneliness 08:50 Nurturing Leadership: The Role of Women in Business 11:55 Breaking Barriers: Gender Diversity in the Workplace 15:03 Funding Challenges: The Struggle for Female Entrepreneurs 17:53 Creating Opportunities: The Club Mamabee Approach 21:05 Engaging the Community: Attracting New Members 24:53 Building Community Through Storytelling 27:14 The Power of Women Supporting Women 30:15 Tangible Outcomes and Growth 32:12 Collaboration Over Competition 34:23 The Health Benefits of Community 36:49 The Role of Women in Leadership 38:30 Timing and the Right Connections 40:39 Shaping the Next Generation of Female Leaders 43:52 Invitation to Join Club Mamabee Guest Information:Guest's Name: Aalyiah HeathGuest's Title/Position:  Director of Editorial & Community Curation Guest's Linkedin: https://www.linkedin.com/in/aalyiah-heath/Company / Affiliation: Club Mamabee https://mamabee.com/Guest's Bio: Aalyiah Heath is a writer, creative strategist, and community curator currently serving as Director of Editorial & Community Curation at Club Mamabee, a platform dedicated to connecting and empowering women leaders. In her role, Aalyiah leads editorial strategy and curates community experiences that foster meaningful dialogue, amplify women’s voices, and create space for thoughtful storytelling and connection. Her work sits at the intersection of editorial content, culture, and community building.  Originally from Detroit, Aalyiah brings a global perspective shaped by her international experiences and creative background in fashion, writing, and communications. She is passionate about the power of storytelling to build community, elevate diverse perspectives, and create spaces where women can share ideas, insights, and lived experiences. Guest's Name: Naomi CosmanGuest's Title/Position:  Marketing Lead Guest's Linkedin: https://www.linkedin.com/in/naomicosman/Company / Affiliation: Club Mamabee https://mamabee.com/Guest's Bio: Naomi Cosman is the Global Head of Marketing at Koning, where she leads the company’s overall marketing strategy, including PR, social media, creative, web, and campaign execution. With a double major in Communications and French from the University of Wisconsin–Madison, Naomi also holds marketing and business certificates from NYU and Harvard Business School.She brings over a decade of marketing experience—five years at a Fortune 500 company in branding and campaign management, followed by five years working with startups across multiple sectors. At Koning, Naomi partners closely with leadership to elevate brand awareness and public engagement, helping position the company as a leader in revolutionary women’s healthcare. In addition to her role at Koning, Naomi is also the Marketing Lead for Club Mamabee, a global community dedicated to connecting and empowering women leaders. Through this work, she helps amplify stories, initiatives, and experiences that support women in leadership, entrepreneurship, and personal growth. TakeawaysBeing emotional is a strength, not a weakness.Women should build spaces of their own.Community is a health intervention, not just a strategy.The hive mentality promotes collaboration and support.Women are excited to join initiatives that empower them.Nurturing qualities in women enhance leadership.Gender diversity leads to increased innovation.Women face unique challenges in securing funding.Club Mamabee offers actionable steps for women in business.Personal stories can attract women to join supportive communities. The importance of storytelling in building community.Personal stories resonate and inspire others to share.Being a mother is a strength in leadership.Women supporting women leads to greater success.Collaboration is more beneficial than competition.Community can reduce burnout and enhance well-being.Women in leadership can break outdated beliefs.Timing and the right connections are crucial for success.Shaping the next generation of female leaders is essential.Everyone has valuable perspectives to contribute. The Healthy Enterprise Podcast is produced by Bullzeye Global Growth Partners  https://bullzeyeglobal.com/

In this conversation, Dylan McDonnell, founder and CEO of Foodini, discusses the challenges faced by individuals with food allergies and dietary restrictions, and how his company aims to provide transparency in food options through technology. He shares his personal journey from being a corporate lawyer to creating a dietary intelligence platform that partners with restaurants to offer personalized menu solutions. The discussion highlights the importance of dietary transparency, the impact of food choices on health, and the potential for restaurants to tap into a growing market by catering to diverse dietary needs. In this conversation, Dylan shares his journey from being a lawyer to founding Foodini, a food tech company focused on addressing food allergies. He discusses the challenges of transitioning from a founder to a CEO, the importance of resilience in the startup world, and the brutal process of fundraising. Dylan emphasizes the significance of building a lean team and staying updated with rapidly evolving technology, particularly AI. He also highlights recent regulatory changes in the food industry that present opportunities for growth and innovation. Chapters: 00:00 Introduction to Food Transparency and Legislation 02:49 Dylan's Journey: From Law to Food Tech 05:52 The Importance of Dietary Transparency 09:09 Understanding Foodini's Technology and Solutions 12:08 Market Expansion and Consumer Discovery 14:50 The Broader Impact of Dietary Needs 17:53 Onboarding Restaurants and Subscription Model 23:27 Transitioning from Lawyer to Entrepreneur 26:00 The Shift from Founder to CEO 28:39 Navigating the Investor Landscape 32:39 Building a Lean and Effective Team 35:00 Staying Ahead in a Rapidly Evolving Tech Landscape 40:39 Regulatory Changes and Opportunities in Food Tech Guest Information:Guest's Name:  Dylan McDonnellGuest's Title/Position:  Founder and CEOGuest's Linkedin: https://www.linkedin.com/in/dylan-mcdonnell-a5787574/Company / Affiliation: Foodini https://foodini.co/Guest's Bio: Dylan McDonnell is the Founder and CEO of Foodini, a foodtech platform connecting the 1 in 3 people with dietary needs to restaurants and menu items suitable for them through a dietitian-led verification model. Motivated by his own experience with Celiac disease, Dylan is focused on building technology that bridges the gap between consumers with dietary requirements and the hospitality industry. Under his leadership, Foodini has gained international recognition, including Startup of the Year (2022) from the International Association of Corporate Counsel and FoodTech CEO of the Year – Australia (2023) from APAC Insider.  Takeaways:California's SB68 bill mandates menu labeling for allergens.Dylan's personal experience with celiac disease inspired Fudini.The market for dietary needs is vast and underserved.Transparency in food options is crucial for consumer trust.Foodini uses AI and dietitian expertise to provide accurate information.Restaurants can reduce allergy incidents with better data.Consumer awareness about food health is increasing.Foodini aims to expand into various food service environments.The onboarding process for restaurants is designed to be simple.Dietary needs impact social interactions and dining experiences. The transition from law to entrepreneurship requires adaptability.Resilience is key in the startup world; expect many rejections.The shift from founder to CEO involves balancing vision and business strategy.Fundraising is a challenging but necessary process for growth.Building a lean team can lead to greater efficiency and innovation.Staying updated with technology is crucial for competitive advantage.Regulatory changes can create significant opportunities in food tech.Understanding your market and consumer needs is essential for success.Strategic investors can provide valuable insights and support.Networking and building relationships are vital in the business landscape. The Healthy Enterprise Podcast is produced by Bullzeye Global Growth Partners  https://bullzeyeglobal.com/

In this conversation, Jonathan López, a medical doctor and founder of karē Corp, discusses his innovative approach to biotech, focusing on a modular platform for drug delivery in extreme environments. He shares his journey from med school to entrepreneurship, the challenges he faced, and his vision for making a global impact, particularly for Puerto Rico. The discussion highlights the importance of real-time health monitoring and the potential applications of his technology in defense and emergency response. Chapters: 00:00 Introduction to Next-Gen Biotech 05:05 The Vision Behind karē Corp 10:00 The Modular Platform Explained 15:11 Real-Time Monitoring and Team Awareness 19:58 Challenges and Growth as a Founder 24:56 The Shift from Cannabis to Defense 29:59 Current Status and Future Aspirations Guest Information:Guest's Name: Jonathan LópezGuest's Title/Position:  Founder & CEOGuest's Linkedin: https://www.linkedin.com/in/jonathanlopez92/Company / Affiliation: karē Corp  https://karembio.com/Guest's Bio: Jonathan López is the Founder and CEO of karē Corp, a physician-trained entrepreneur focused on building regulated, science-first human performance systems. His work centers on the development of advanced subcutaneous infusion platforms that integrate pharmacology, hardware, and software to support human health and performance in demanding environments. Jonathan leads the company’s strategy across FDA-regulated development pathways, intellectual property creation, and dual-use deployment for civilian healthcare, first responders, defense, and space applications. He is currently advancing multiple patented platforms designed to align with federal innovation and research programs, with the goal of delivering next-generation biomedical solutions for extreme and mission-critical environments. Takeaways:Jonathan López is building next-gen biotech platforms for drug delivery.karē Corp aims to provide real-time health monitoring in extreme environments.The platform is modular and can be tailored for different users like soldiers and astronauts.Real-time data can help prevent medical emergencies in the field.Jonathan's journey reflects the challenges of pursuing innovation in healthcare.He emphasizes the importance of inspiring Puerto Ricans to believe in their potential.The shift from cannabis to defense technology was a strategic decision for broader impact.Jonathan faced external doubt from family and friends about his entrepreneurial path.The technology aims to enhance human performance in critical situations.Jonathan is currently in the process of securing grants and patents for his innovations.The Healthy Enterprise Podcast is produced by Bullzeye Global Growth Partners  https://bullzeyeglobal.com/

This episode is part of a limited series called Money Ball in conjunction with the BLPN Club . BLPN's Money Ball program helps founders step up to the plate and knock fundraising out of the park. You'll hear about the people, their ventures, and their pitch-making experiences. In this episode of The Healthy Enterprise, host Heath Fletcher speaks with Chandi Bandara, CEO of Precision Quantomics, about the challenges and innovations in drug development. They discuss the inefficiencies in the pharmaceutical industry, the importance of effective pitching to investors, and the insights gained from the Money Ball program. Chandi shares his journey from a molecular biologist to a CEO, the lessons learned in storytelling for pitches, and the significance of feedback in refining business strategies. The conversation emphasizes the need for entrepreneurs to seek guidance and input from experienced peers in their journey. Chapters: 00:00 Introduction to The Healthy Enterprise and Money Ball Series 00:39 Chandi Bandara: CEO of Precision Quantomics 02:04 Innovative Solutions in Drug Development 03:49 Company Progress and Market Presence 05:07 Chandi's Journey to Precision Quantomics 06:26 The Art of Pitching to Investors 09:00 Crafting the Perfect Pitch Story 11:28 Refining the Pitch with Money Ball Program 13:30 Learning from Investor Feedback 15:22 Common Mistakes in Pitching 18:17 Unique Perspective as a Non-Founder CEO 20:03 Impact of Money Ball Program on Pitching 22:28 Advice for Aspiring Entrepreneurs 25:54 Conclusion and Future Aspirations Guest Information:Guest's Name: Chandi BandaraGuest's Title/Position:  Chief Executive OfficerGuest's Linkedin: https://www.linkedin.com/in/cabandara/Company / Affiliation: Precision Quantomics https://precisionquantomics.com/Guest's Bio:  Chandima Bandara is CEO of Precision Quantomics, where he leads the company’s mission to transform drug development through high-precision proteomics. With more than 20 years of experience across biotechnology, contract research, business development, and large-scale operations, he brings a unique blend of scientific expertise and operational leadership to the biotech industry. He began his career in R&D before scaling growth at a leading CRO and later managing world-class logistics operations at Amazon. Over the past six years, he has focused on commercializing scientific innovation through life sciences startups. At Precision Quantomics, he is building a comprehensive proteomics database, LC-MS kit portfolio, and testing-as-a-service platform to accelerate pharmaceutical R&D and reduce costs. Chandima also serves on the Board of Trustees for the Health Sciences & Services Authority of Spokane County and contributes to national initiatives advancing regulatory science and New Approach Methodologies.Takeaways:Precision Quantomics addresses inefficiencies in drug development.90% of drugs fail to reach the market due to outdated models.Chandi Bandara transitioned from science to business development.Effective pitching requires understanding the audience's perspective.The Money Ball program helped refine Chandi's pitch.Investors need to hear the problem and solution quickly.Iterating on the pitch deck is crucial for success.Feedback from investors is invaluable for improvement.Every entrepreneur's journey is unique and requires tailored advice.Building a supportive ecosystem is essential for startup growth.

This episode is part of a limited series called Money Ball in conjunction with the BLPN Club. BLPN's Money Ball program helps founders step up to the plate and knock fundraising out of the park. You'll hear about the people, their ventures, and their pitch-making experiences. In this episode of The Healthy Enterprise, host Heath Fletcher interviews Doug Cohen, the Co-Founder and CEO of IR Medtek, about his journey in developing a groundbreaking technology for cancer detection. Doug shares his unique background in mechanical engineering and how it led him to identify a significant gap in the healthcare market, particularly in skin cancer detection. The conversation delves into the development process of their innovative device, the challenges faced, and the importance of refining their pitch to investors through the Money Ball program. Doug emphasizes the value of collaboration, confidence in their technology, and the potential impact on patient care. Chapters: 00:00 Introduction to Money Ball and IR Medtek 01:14 Doug's Unique Background and Journey 02:27 Identifying the Gap in Cancer Detection 05:51 The Development Journey of the Technology 07:41 Current Progress and Future Steps 08:39 Understanding the Device and Its Functionality 10:58 Enhancing Primary Care with Technology 13:25 Investor Response and Presentation Experience 14:34 Refining the Pitch through Money Ball 18:32 Public Speaking and CEO Responsibilities 21:12 The Advantage of an Engineering Background 24:11 Reflections on the Money Ball Experience Guest Information:Guest's Name: Doug CohenGuest's Title/Position: Chief Executive OfficerGuest's Linkedin: https://www.linkedin.com/in/doug-cohen-64761410/Company / Affiliation: IR Medtek https://www.irmedtek.com/Guest's Bio:  Doug Cohen is IR Medtek's Co-Founder and CEO and has over 20 years of experience in manufacturing equipment, product design, global sourcing, and logistics. Doug is a graduate of MIT in mechanical engineering and has experience as both an owner and investor in start-ups. He owns a number of technology patents and serves on the board of the public company Organovo. Takeaways:Doug's background in mechanical engineering shaped his approach to IR Medtek.The technology developed can differentiate tumor from non-tumor tissue.Skin cancer detection is a significant market opportunity.The device provides real-time feedback to primary care doctors.Investor confidence is crucial for the success of startups.Refining the pitch can significantly improve investor engagement.Public speaking skills are essential for CEOs in fundraising.Collaboration with experts enhances the team's capabilities.The Money Ball program provided valuable networking opportunities.The technology has the potential to improve patient outcomes significantly. The Healthy Enterprise Podcast is produced by Bullzeye Global Growth Partners  https://bullzeyeglobal.com/

This episode is part of a limited series called Money Ball in conjunction with the BLPN Club . BLPN's Money Ball program helps founders step up to the plate and knock fundraising out of the park. You'll hear about the people, their ventures, and their pitch-making experiences. In this episode, Rob Boyce, CEO of Plakous Therapeutics, discusses the company's mission to develop regenerative medicine solutions for necrotizing enterocolitis (NEC), a devastating disease affecting premature infants. He shares insights into the challenges of developing treatments for this vulnerable population, the importance of funding, and the role of networking in the biotech industry. Rob also highlights a case study of a patient named Laurel, illustrating the potential impact of their product on improving outcomes for babies at risk of NEC. Chapters: 00:00 Introduction to Plakous Therapeutics 01:08 Understanding Necrotizing Enterocolitis (NEC) 04:23 The Genesis of Plakous Therapeutics 06:24 Innovative Approach to Treatment 09:27 Real-Life Impact: Case Study of Laurel 13:32 Navigating the Funding Landscape 16:06 Refining the Pitch Process 22:05 Challenges in the Current Investment Climate 25:11 Current Stage and Future Plans Guest Information:Guest's Name: Robert BoyceGuest's Title/Position:  Chief Executive OfficerGuest's Linkedin:https://www.linkedin.com/in/robertwboyce/Company / Affiliation: Plakous Therapeutics https://www.plakoustherapeutics.com/Guest's Bio:  Rob Boyce is the CEO of Plakous Therapeutics, Rob has been working in healthcare and life sciences throughout his career. He has been part of several start-up companies. Prior to Plakous Rob was at Imago Systems, Inc., a software as a service medical diagnostic company seeking to redefine the medical imaging. He started his business career at Johnson & Johnson, marketing the Tylenol Brand. While at J&J he led worldwide Sales and Marketing for Independence Technology, a Johnson & Johnson company specializing in state-of-the-art rehabilitation technology. Rob launched his career as a naval flight officer in the Navy’s E-2C Hawkeye. Takeaways:Rob Boyce is the CEO of Plakous Therapeutics, focusing on regenerative medicine.Necrotizing enterocolitis (NEC) is a severe condition affecting premature infants.The last FDA-approved medicine for NICU babies was in 1991.Plakous's product mimics amniotic fluid to support GI tract development.Laurel's case illustrates the challenges faced by NEC patients.Funding for pediatric biotech is particularly challenging.Networking and preparation are crucial for successful investor pitches.Understanding the audience is key to effective presentations.Regulatory pathways for pediatric treatments are complex and uncertain.Plakous aims to raise $8 million for further development. The Healthy Enterprise Podcast is produced by Bullzeye Global Growth Partners https://bullzeyeglobal.com/

This episode is part of a limited series called Money Ball in conjunction with the BLPN Club . BLPN's Money Ball program helps founders step up to the plate and knock fundraising out of the park. You'll hear about the people, their ventures, and their pitch-making experiences. In this conversation, James Lovgren shares his insights on the funding process for biotech startups, emphasizing the importance of team expertise, the art of pitching, and the need to balance scientific detail with storytelling. He discusses the iterative nature of pitching, the significance of understanding investor expectations, and the value of targeting the right investors to enhance the chances of success. James reflects on his experiences in the Money Ball program, highlighting the lessons learned and the importance of adaptability in investor conversations. Chapters: 00:00 Introduction to Money Ball and Aspiro Therapeutics 01:13 Understanding Obstructive Lung Diseases 02:59 Innovative Solutions in Lung Disease Treatment 05:04 The Journey of Aspiro Therapeutics 07:05 The Importance of Team Dynamics 09:09 Mastering the Pitch Process 10:50 Evolving the Pitch: Lessons Learned 12:58 Investor Engagement and Feedback 14:56 Navigating Investor Relationships 17:09 Refining the Pitch Through Iteration 19:01 The Role of Investor Fit 21:07 Future Directions for Aspiro Therapeutics Guest Information:Guest's Name: James LovgrenGuest's Title/Position:  CEO & Co-FounderGuest's Linkedin: https://www.linkedin.com/in/jameslovgren/Company / Affiliation: Aspiro Therapeutics https://aspirotx.com/Guest's Bio:  As the CEO of Aspiro Therapeutics, James Lovgren leads the company’s mission to revolutionize the treatment of obstructive lung diseases with innovative CC16-inspired therapies. James is an accomplished life science executive with a distinguished track record of commercializing disruptive technologies and managing global product portfolios exceeding $250 million. His extensive background spans startups, growth-stage companies, and Fortune 150 biotechnology firms, where he has successfully brought a wide range of products, services, and reagents to market in the pharmaceutical, diagnostics, and life science sectors. James’ strategic insight and operational expertise are instrumental in guiding Aspiro Therapeutics through its preclinical development stage and beyond. Takeaways:Investors prioritize team expertise in funding decisions.The pitching process requires practice and iteration.Balancing scientific detail with storytelling is crucial.Understanding investor backgrounds can shape the pitch.Feedback from peers can refine the pitch effectively.High-level narratives often resonate more than technical data.Each investor may have different areas of interest.Flexibility in presentation can lead to better engagement.Building a targeted investor list saves time and effort.Long-term relationships with investors are essential for success. The Healthy Enterprise Podcast is produced by Bullzeye Global Growth Partners  https://bullzeyeglobal.com/

In this episode of the Healthy Enterprise podcast, host Heath Fletcher engages with Elissa Zylbershlag, Founder of Work Wise Labs, who specializes in proactive HR strategies and positive workplace environments. Elissa shares her journey from being an anti-bias educator to establishing her own business, emphasizing the importance of fostering a positive work culture. She explains the concept of anti-bias education, which aims to create a more just and equitable world, and how it connects to workplace dynamics. Alissa also introduces the principles of positive psychology, highlighting how focusing on strengths rather than weaknesses can lead to a more fulfilling and productive work life. Chapters: 00:00 Introduction to Elissa Zylbershlag and Work Wise Labs 01:23 Understanding Anti-Bias Education 07:06 The Shift to Positive Psychology 13:52 Work Wise Labs: Services and Offerings 20:41 The Journey to Entrepreneurship 22:10 Challenges Faced by Leaders Today 26:27 The Role of Coaching in Personal Development 27:15 The Dynamics of Coaching Relationships 29:29 Prioritizing Personal Needs in Leadership 30:56 The Importance of Self-Awareness 33:20 Understanding Perceptions: The Portrait Analogy 39:20 The One, Two, Three Theory of Feedback 42:15 Embracing Growth and New Opportunities 44:13 Networking and Building Connections 46:19 Transforming Conflict into Connection Guest Information:Guest's Name: Elissa ZylbershlagGuest's Title/Position:  FounderGuest's Linkedin: https://www.linkedin.com/in/elissazylbershlag/Company / Affiliation: Work Wise Labs https://www.workwiselabs.com/Guest's Bio: Elissa Zylbershlag, M.Ed. is the Founder of Work Wise Labs and a leadership development and team-building professional who helps nonprofits, universities, and small organizations create healthier, more connected workplaces. Through proactive coaching, interactive workshops, and culture-focused training, she works 1:1 with leaders and facilitates engaging group sessions that strengthen communication, trust, confidence, and collaboration—always with a focus on making work both productive and enjoyable. Through Work Wise Labs, Elissa equips organizations with practical tools to build supportive, mission-aligned cultures where people actually want to show up for work. Takeaways:Different does not mean bad.Focusing on strengths makes you happier and makes your life more meaningful.Coaching is about possibility, what's possible, and it's about action plan.The workplace is a hotbed of bias and discrimination.Positive psychology looks at what's right with people, not what's wrong.Coaching relationships can last from months to decades, depending on individual needs.Self-awareness is crucial in leadership; it's about understanding how others perceive you.Feedback from multiple sources can reveal patterns in behavior and perceptions.Addressing conflict can improve relationships 75% of the time when done correctly.Prioritizing your own needs is essential before helping others. The Healthy Enterprise Podcast is produced by Bullzeye Global Growth Partners  https://bullzeyeglobal.com/

In this episode, Katie Saindon, Senior Director of Product at Qventus, discusses her journey in product management and the innovative solutions Qventus provides to healthcare systems. The conversation covers the challenges faced by health systems, the role of AI in automating care operations, and the importance of seamless integration with existing workflows. Katie shares insights on the impact their platform can make on patient discharge processes and surgical operations. The discussion highlights the collaborative approach they take with clients to develop tailored solutions that enhance patient care and operational efficiency. Chapters: 00:00 Introduction to Katie Saindon and Qventus 02:53 Katie's Journey into Product Management 05:45 Understanding Qventus and Its Solutions 09:01 The Impact of Qventus on Patient Discharge 12:00 AI as a Teammate in Healthcare 15:09 Optimizing Surgical Operations with Qventus 17:51 Integration Challenges and Solutions 21:05 Growth and Funding Stages of Qventus 24:09 Competitive Landscape and Client Partnerships 26:59 Innovative Solutions and Case Studies 30:08 Marketing and Outreach Strategies 32:55 Future of Qventus and Healthcare Technology Guest Information:Guest's Name:  Katie SaindonGuest's Title/Position:  Senior Director of Product ManagementGuest's Linkedin: https://www.linkedin.com/in/katie-saindon/Company / Affiliation: Qventus https://www.qventus.com/Guest's Bio: Katie Saindon is Senior Director of Product Management at Qventus, where she leads product strategy and execution for AI-driven healthcare solutions. An intrinsically motivated and passionate product leader, Katie brings global experience driving vision, roadmap, and delivery to generate revenue and elevate customer satisfaction. She’s known for balancing short- and long-term priorities with radical clarity—keeping outcomes front and center to deliver meaningful value for both customers and the business. Takeaways:Katie Saindon is the Senior Director of Product at Qventus.Qventus automates care operations across the entire patient journey.The company helps alleviate administrative burdens on healthcare staff.AI is positioned as a teammate to support healthcare professionals.Qventus aims to optimize patient discharge processes.The integration of Qventus solutions with existing EHR systems is crucial.The company is in a Series D funding stage, indicating rapid growth.Client partnerships are key to developing innovative solutions.Qventus has seen significant reductions in patient wait times and denials.The future of healthcare technology is focused on collaboration and integration. The Healthy Enterprise Podcast is produced by Bullzeye Global Growth Partners  https://bullzeyeglobal.com/

In this episode of The Healthy Enterprise, guest Martin Tsui shares his journey from scientist to entrepreneur and the founding of his biotech startup, ncrspt. The conversation explores how CRISPR technology can be used for DNA-based data storage, offering a radically new approach to long-term, secure data preservation. Tsui breaks down the science behind CRISPR in accessible terms, discusses the fundraising challenges faced by deep-tech biotech startups, and highlights potential applications of DNA data storage—particularly in healthcare. The episode also examines the growing role of AI in data management, the future of data preservation, and why biological systems may hold the key to storing information at unprecedented scale and durability. Chapters: 00:00 Introduction to Martin Tsui and ncrspt 02:52 Martin's Journey in Science and Technology 05:59 The Birth of ncrspt 08:48 Understanding CRISPR Technology 12:03 Current Stage of ncrspt and Challenges 15:01 Innovative Data Storage Solutions 18:02 The Science Behind DNA Data Storage 20:56 Applications of DNA Data Storage 23:51 Navigating the Investment Landscape 27:04 Future Prospects and Applications of ncrspt 29:57 The Challenges of DNA Data Storage 32:56 The Process of Storing Data in DNA 36:54 The Future of Data Centers 38:00 Applications in Healthcare and Beyond 40:32 The Role of AI in Data Storage 42:24 Innovative Data Transfer Methods 45:03 The Future of Data Preservation 48:40 The Vision for Data Storage Technology Guest Information:Guest's Name: Martin TsuiGuest's Title/Position:  Founder & CEOGuest's Linkedin: https://www.linkedin.com/in/t-k-martin-tsui/Company / Affiliation: ncrspt https://www.ncrspt.com/Guest's Bio: T.K. Martin Tsui is the Founder & CEO of ncrspt, a biotech platform pioneering the preservation of digital data in living cells using DNA-based storage technology. Under his leadership, ncrspt is developing proprietary methods to encode any digital format into biological systems for secure, long-term archiving across industries including healthcare, government, and enterprise. Tsui has a background in structural biochemistry and CRISPR research, with a Ph.D. in Molecular Biophysics and experience applying cutting-edge molecular biology techniques to solve complex scientific challenges before turning to deep tech entrepreneurship. Takeaways:Martin Tsui is the founder and CEO of ncrspt.ncrspt focuses on using CRISPR technology for data storage.CRISPR technology has applications in genome engineering and beyond.The startup was born out of a layoff experience at Amazon.Investors are often hesitant to fund biotech startups due to perceived risks.DNA can store vast amounts of data in a small volume.The density of DNA data storage is significantly higher than traditional methods.ncrspt aims to keep data for decades or centuries.The company is currently in the process of fundraising and developing prototypes.Understanding the science behind CRISPR is crucial for its applications.  The technology requires cutting DNA into smaller pieces for storage.Quality control is essential in the DNA data storage process.Storing data in DNA can provide a secure backup solution.The process involves converting files into DNA sequences.Genome engineering tools like CRISPR are used in data insertion.Data can be preserved for long periods using biological methods.AI currently cannot access data stored in DNA.Innovative methods for data transfer can include space travel.The technology has potential applications in healthcare and national security.Raising awareness about DNA data storage is crucial for its adoption. The Healthy Enterprise Podcast is produced by Bullzeye Global Growth Partners  https://bullzeyeglobal.com/

In this episode of The Healthy Enterprise, Annie Stephanos shares her journey from burnout to becoming a certified life, mental health, and wellness coach. She discusses the realities of burnout, the difference between coaching and therapy, and how women can build sustainable routines, set healthy boundaries, and prioritize self-care. Annie also reflects on her entrepreneurial path with Highroads Coaching and offers practical tools for creating meaningful, lasting change. Chapters: 00:00 Introduction to Highroads Coaching 02:54 The Journey to Coaching 06:44 Understanding Burnout 10:34 The Layers of Burnout 15:31 Preventing Burnout 19:18 The Importance of Rest 22:01 Coaching vs. Therapy 30:27 The Reward of Coaching 31:52 The Importance of Coaching for Coaches 34:47 Navigating the Entrepreneurial Journey 39:54 Marketing Strategies in a Saturated Market 44:22 Leveraging Technology and AI in Coaching 49:04 Advice for Aspiring Coaches and Those Facing Burnout Guest Information:Guest's Name: Annie StephanosGuest's Title/Position:  FounderGuest's Linkedin: https://www.linkedin.com/in/highroadscoaching/Company / Affiliation: Highroads Coaching https://highroadscoaching.com/Guest's Bio: Annie Stephanos, M.Ed., CMHC, CPLC is a life, mental health, and wellness coach who helps individuals reconnect with themselves and build sustainable paths to balance and well-being. A former educational coach and Founder of Highroads Coaching, she empowers clients to recognize that the capacity for meaningful change has been within them all along. Annie brings a deep passion for guiding people toward their goals, grounded in her core values of hope, trust, and compassion, shaped by her own journey through burnout and PTSD. Takeaways:Annie Stefanos is a certified mental health and wellness coach.She helps high-achieving women recover from burnout.Burnout can stem from various sources, including workplace stress and societal pressures.Support systems are crucial for recovery from burnout.Coaching focuses on future goals, while therapy often addresses past issues.Setting healthy boundaries is essential for mental well-being.Rest is often undervalued in a productivity-driven society.Women need to be heard and supported in their struggles with burnout.Creating sustainable routines can help prevent burnout.Every client has unique needs, and coaching should be tailored to them. Never think you can do it all alone; it takes a village.Continuous learning and feedback are essential in coaching.Starting a business can be easier with the right support.Standing out in a saturated market requires a unique story.Word of mouth is the most effective marketing strategy.Coaching is a valuable investment in oneself.Don't wait for burnout to seek help; reach out early.Having a niche helps in establishing a coaching business.Coaching provides actionable tools for immediate change.You are worth investing in your mental health and well-being. The Healthy Enterprise Podcast is produced by Bullzeye Global Growth Partners  https://bullzeyeglobal.com/

In this episode of The Healthy Enterprise Podcast, Dr. Merle Griff, Founder and CEO of SarahCare Senior Solutions, shares her journey in senior care and the evolution of adult day health services. She explores the value of intergenerational programs, lessons from caregiving during COVID-19, and the leadership challenges of scaling a franchise model. Dr. Griff also discusses restorative nursing, technology-enabled care, regulatory realities, and insights from her book Solace in the Storm, offering practical guidance for family caregivers. Chapters: 00:00 Introduction to Senior Care Solutions 01:47 The Journey of a Caregiver 04:50 Changing Perspectives on Senior Care 06:55 The Impact of COVID-19 on Caregiving 10:27 Intergenerational Connections in Care 16:01 Franchising Senior Care Services 24:41 Evolving Leadership in Senior Care 27:05 Restorative Nursing and Its Impact 28:46 Franchise Model and Business Philosophy 30:42 Community and Support Among Franchisees 32:15 Innovation and Technology in Care 34:40 Growth and Expansion Plans 37:39 Attracting Franchisees and Market Viability 40:15 Navigating Regulations and Technology Challenges 42:11 Advice for Aspiring Franchisees 45:49 Introduction to 'Solace in the Storm' Book 49:55 Closing Thoughts and Resources Guest Information:Guest's Name: Merle Griff Guest's Title/Position:  Founder & CEO Guest's Linkedin: https://www.linkedin.com/in/drmerlegriff/Company / Affiliation: SarahCare Senior Solutions  https://sarahcare.com/ Guest's Bio: Merle D. Griff, Ph.D. is the Founder & CEO of SarahCare and one of the leading authorities on senior care in the United States. She has served in national leadership roles including Past Chair of the National Adult Day Services Association (NADSA), member of CARF’s International Advisory Board, and as a federal task force contributor to the U.S. Department of Aging. A former play therapist, Dr. Griff developed widely adopted Family Play Therapy and Intergenerational Play Therapy models and is the author of Linkages, along with numerous scholarly publications. She also hosts the podcast Caught Between Generations, focused on the challenges facing caregivers in the sandwich generation. Takeaways:Dr. Merle Griff emphasizes the importance of community in senior care.Caregiving experience provides valuable insights into the needs of seniors.COVID-19 has shifted perceptions about home-based care.Intergenerational programs foster relationships between seniors and children.Franchising allows for the expansion of high-quality senior care services.Staffing in adult day care is often easier than in nursing homes.Caregivers need respite to maintain their health and well-being.Engagement in activities significantly improves seniors' quality of life.The role of family caregivers is evolving with younger generations taking charge.Building relationships with families enhances the caregiving experience. Restorative nursing helps patients make progress at a slower rate.The franchise model allows for high standards of care across multiple locations.Franchisees benefit from a supportive community and shared experiences.Technology plays a crucial role in modernizing care practices.Growth in adult day health is expected as demand increases post-COVID.Studio 55 caters to active seniors needing social engagement.Franchisees are attracted through online portals and demographic analysis.Navigating state regulations is essential for successful expansion.Financial literacy is critical for franchisee success.'Solace in the Storm' provides practical tips for family caregivers. The Healthy Enterprise Podcast is produced by Bullzeye Global Growth Partners  https://bullzeyeglobal.com/

Chris Dayton, Co-Founder & CEO of Quality Assured AI, explores how AI is being responsibly integrated into the pharmaceutical industry, with a focus on quality management, regulatory compliance, and data security. He discusses the use of closed systems and air-gapped architectures to protect sensitive data, the challenges of deploying AI in regulated environments, and the importance of mitigating hallucinations in AI models. Chris also shares lessons from launching and scaling the platform, transitioning into the CEO role, and building AI literacy within organizations—highlighting how thoughtful AI adoption can drive innovation while reducing operational strain and burnout. Chapters: 00:00 Introduction to Quality Assured AI 02:51 The Role of AI in Pharmaceuticals 06:02 Understanding AI Implementation Challenges 09:04 The Importance of Data Security 11:50 Navigating Regulatory Compliance 15:00 The Evolution of AI in Quality Management 17:59 The Human Element in AI Integration 20:56 Client Onboarding and Customization 23:49 Feedback and Market Reception 26:59 Future Growth and Scalability 29:50 Parting Thoughts and Advice Guest Information:Guest's Name: Chris DaytonGuest's Title/Position:  Co-Founder & CEOGuest's Linkedin: https://www.linkedin.com/in/chris-dayton-b414bb57/Company / Affiliation: Quality Assured AI  https://www.qualityassured.ai/Guest's Bio: Chris Dayton is the Co-Founder and CEO of Quality Assured Ai, a company delivering closed-system, on-premise AI solutions purpose-built for pharmaceutical Quality Assurance and Quality Management. With over a decade of experience across protein, cell, and gene therapy manufacturing, he has served as a lead investigator, QMS author, and technical operations manager overseeing QDS authorship and validation approvals. Chris has designed and deployed AI/ML models that streamline deviation drafting, SOP generation, and CAPA support while maintaining strict compliance with FDA, EMA, and MHRA regulatory frameworks. He has consulted with top-25 global pharmaceutical companies on GxP-aligned AI pilots and is a recognized thought leader in AI governance for life sciences, speaking at PDA events and leading AI literacy initiatives for QA and regulatory professionals. Takeaways:Quality Assured AI focuses on the quality and regulatory side of pharmaceuticals.AI can significantly reduce the time needed for documentation in the pharmaceutical industry.Closed system deployments ensure data security and compliance with regulations.Understanding and addressing hallucinations in AI is crucial for reliability.AI should not continuously learn from user interactions in regulated environments.Effective training and onboarding are essential for successful AI integration.Feedback from users highlights the practical benefits of AI in quality management.Collaboration with consulting groups enhances scalability and deployment efficiency.AI literacy is vital for stakeholders in the pharmaceutical industry.Future growth includes expanding AI capabilities to automate more processes.  The Healthy Enterprise Podcast is produced by Bullzeye Global Growth Partners  https://bullzeyeglobal.com/